22.728 articles found

GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease.

Wang F, Kameda M, Yasuhara T, Tajiri N, Kikuchi Y, Liang HB, Tayra JT, Shinko A, Wakamori T, Agari T, Date I.

Neurosci Res · 2011-06-15

DOI: 10.1016/j.neures.2011.05.019PMID: 21699926

Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.

Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, Bienfait KL, Friedman J.

Am J Psychiatry · 2011-06-15

DOI: 10.1176/appi.ajp.2011.10111669PMID: 21676990

METHOD FOR THE DIFFERENTIATION OF ADULT STEM CELLS INTO NEURAL PROGENITOR CELLS USING TWO-DIMENSIONAL CULTURE, AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES CONNECTED TO NEURAL DAMAGE USING THE NEURAL PROGENITOR CELLS

MOON JI-SOOK, LEE HYUN-SEOB.

· 2011-06-14

Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.

Spielman J, Mahler L, Halpern A, Gilley P, Klepitskaya O, Ramig L.

J Commun Disord · 2011-06-13

DOI: 10.1016/j.jcomdis.2011.05.003PMID: 21724193

Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease.

Strutt AM, Simpson R, Jankovic J, York MK.

Eur J Neurol · 2011-06-11

DOI: 10.1111/j.1468-1331.2011.03447.xPMID: 21668586

From the bench to the bedside: Gene therapy for Parkinson's disease, The roles of the habenula and nucleus accumbens in depression, Microglia and neurodegeneration.

Bari AA, Hauptman JS.

Surg Neurol Int · 2011-06-09

DOI: 10.4103/2152-7806.81967PMID: 21748026

Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease.

Garbayo E, Ansorena E, Lanciego JL, Blanco-Prieto MJ, Aymerich MS.

Mov Disord · 2011-06-09

DOI: 10.1002/mds.23793PMID: 21661048

The role of cognitive-behavioural therapy for patients with depression in Parkinson's disease.

Charidimou A, Seamons J, Selai C, Schrag A.

Parkinsons Dis · 2011-06-08

DOI: 10.4061/2011/737523PMID: 21766001

Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease.

Tambasco N, Belcastro V, Gallina A, Castrioto A, Calabresi P, Rossi A.

J Neurol · 2011-06-08

DOI: 10.1007/s00415-011-6119-5PMID: 21647729

Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Jicha GA.

J Mol Neurosci · 2011-06-07

DOI: 10.1007/s12031-011-9558-7PMID: 21647712

MELLITIN FOR THE USE THEREOF IN THE TREATMENT OF PARKINSON'S DISEASE

HARTMANN ANDREAS.

· 2011-06-06

WITHDRAWN: Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

Liu K, Liu C, Shen L, Shi J, Zhang T, Zhou Y, Zhou L, Sun X.

Neurochem Int · 2011-06-06

DOI: 10.1016/j.neuint.2011.05.011PMID: 21672587